Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Pneumonia and Septic Shock.

The Journal of clinical endocrinology and metabolism(2022)

引用 5|浏览8
暂无评分
摘要
Among DM patients, SGLT2is reduced the risk of pneumonia and septic shock compared with placebo. Our findings should be viewed as hypothesis generating, with concepts requiring validation in future studies.
更多
查看译文
关键词
diabetes,pneumonia,respiratory tract infections,septic shock
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要